Author(s): Michael Tarantino, James Bussel, Victor Blanchette, et al. Abstract: PF655 Session topic: 33. Platelets disorders Background Children with ITP for ≥6 months who completed a romiplostim phase 1/2 or 3 study could enter an open label extension. Aims Final extension data for these children with ITP treated with romi- plostim...
Pro zobrazení tohoto obsahu je třeba být přihlášen.